Cleared Traditional

K080642 - COMPREHENSIVE REVERSE SHOULDER (FDA 510(k) Clearance)

Jul 2008
Decision
125d
Days
Class 2
Risk

K080642 is an FDA 510(k) clearance for the COMPREHENSIVE REVERSE SHOULDER. This device is classified as a Shoulder Prosthesis, Reverse Configuration (Class II - Special Controls, product code PHX).

Submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on July 9, 2008, 125 days after receiving the submission on March 6, 2008.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3660. Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint..

Submission Details

510(k) Number K080642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2008
Decision Date July 09, 2008
Days to Decision 125 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code PHX — Shoulder Prosthesis, Reverse Configuration
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3660
Definition Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.

Similar Devices — PHX Shoulder Prosthesis, Reverse Configuration

All 39
INHANCE™ Reverse Shoulder System
K253624 · Depuy Ireland UC · Mar 2026
MSS - Monobloc stem
K250644 · Medacta International S.A. · Feb 2026
SMR Shoulder System
K252352 · Lima Corporate S.P.A. · Jan 2026
AltiVate Reverse® ADLC Glenosphere
K252567 · Encore Medical, L.P. · Jan 2026
Tornier Perform™ Reversed Monopost Glenoid (Perform Mono)
K252788 · Tornier, Inc. · Jan 2026
MSS - Humeral reverse liners extension
K250338 · Medacta International S.A. · Oct 2025